US Patent Litigations are now available. Check here

IP Verse

Pharmaceutical Compositions Of Pemetrexed

PatentPatent Analysis

EP2854768

FRESENIUS KABI ONCOLOGY
Application Number
EP13730070A
Filing Date
May 30, 2013
Status
Granted And Under Opposition
Feb 17, 2017
Grant Date
Mar 22, 2017
External Links
Slate, Register, Google Patents

Biblio Summary

The patent EP2854768B1 was granted on Mar 22, 2017 by Fresenius Kabi Oncology The patent is currently Granted And Under Opposition.

Patents Cited during Opposition New

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionCN101081301
 N/A
OppositionCN100364993C
 N/A
OppositionWO2012015810
 N/A
OppositionWO2010030598
 N/A
OppositionWO2014167585
 N/A
OppositionIS50051
 N/A
OppositionUS2007190138
 N/A
OppositionUS5344932
 N/A
OppositionEP0432677
 N/A
OppositionWO2008021411
 N/A
OppositionUS4977181
 N/A
OppositionEP1313508
 N/A

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents